Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | PGR | P06401 | 5/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.40 |
| ▸ | TDP2 | O95551 | 2/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24588640 | 0.82 | HTR1A (0.36) | HTR1AHTR7 | |
| SCHEMBL21225981 | 0.82 | HTR1A (0.39) | PDK2HTR1AHTR7 | |
| SCHEMBL19429151 | 0.79 | PTGS2 (0.41) | HTR1AHTR7KMT2A | |
| SCHEMBL22600972 | 0.76 | TDO2 (0.41) | TAAR1ALOX5MAOBPDK2HTR1A | |
| SCHEMBL21879767 | 0.75 | HTR1A (0.33) | HTR1AHTR7 | |
| SCHEMBL31223184 | 0.75 | HTR1A (0.33) | HTR1AHTR7 | |
| SCHEMBL31223183 | 0.75 | HTR1A (0.33) | HTR1AHTR7 | |
| SCHEMBL31223188 | 0.75 | HTR1A (0.33) | HTR1AHTR7 | |
| SCHEMBL31223187 | 0.75 | HTR1A (0.33) | HTR1AHTR7 | |
| SCHEMBL24589172 | 0.74 | PTGS2 (0.37) | ESR2PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651391-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20190245148-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-08-08 | — | — | US | disclosed |
| US-10319915-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2019-06-11 | — | — | US | disclosed |
| US-20180151806-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-31 | — | — | US | disclosed |
| US-20180151806-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-31 | — | — | US | disclosed |
| US-20170237013-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2017-08-17 | — | — | US | disclosed |
| US-20170237013-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10319915-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | EML4, EBPL, NFE2L2 | TAAR1 4409/4885ESR2 20/4885ALOX5 1123/4885 |
| US-20170237013-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EML4, EBPL, NFE2L2 | TAAR1 4409/4885ESR2 20/4885ALOX5 1123/4885 |
| US-20190245148-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EML4, EBPL, NFE2L2 | TAAR1 4409/4885ESR2 20/4885ALOX5 1123/4885 |
| US-20180151806-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EBPL, EML4, NFE2L2 | TAAR1 4336/4885ESR2 26/4885ALOX5 791/4885 |
| US-10651391-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | EML4, EBPL, NFE2L2 | TAAR1 4409/4885ESR2 20/4885ALOX5 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.